from CRISIL
Ipca Laboratories announced the revision in credit ratings of the Company for bank loan facilities aggregating Rs 1182.5 crore -Long term rating - CRISIL AA-/ Stable (Withdrawn at the request of the Company)
Rs 5 crore NCDs - CRISIL AA-/ Stable (Reaffirmed)
Rs 50 crore Short term debt - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
